150 related articles for article (PubMed ID: 35194143)
1. Gini's mean difference and the long-term prognostic value of nodal quanta classes after pre-operative chemotherapy in advanced breast cancer.
Vinh-Hung V; Van Parijs H; Gorobets O; Fontaine C; Nguyen NP; Keam B; Nguyen DM; De Ridder M
Sci Rep; 2022 Feb; 12(1):2983. PubMed ID: 35194143
[TBL] [Abstract][Full Text] [Related]
2. Twenty-five Years Overall Survival Prognostic Value of the Lymph Node Ratio in
Gorobets O; Keam B; Vinh-Hung V; Nguyen NP
Anticancer Res; 2024 May; 44(5):1995-2002. PubMed ID: 38677759
[TBL] [Abstract][Full Text] [Related]
3. Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: Prognostic Value Measured with Gini's Mean Difference of Restricted Mean Survival Times.
Keam B; Gorobets O; Vinh-Hung V; Im SA
Cancer Inform; 2021; 20():11769351211051675. PubMed ID: 34671180
[TBL] [Abstract][Full Text] [Related]
4. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
5. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
7. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
8. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
10. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?
Saxena N; Hartman M; Yip CH; Bhoo-Pathy N; Khin LW; Taib NA; Looi LM; Lim SE; Lee SC; Verkooijen HM
PLoS One; 2012; 7(9):e45809. PubMed ID: 23029254
[TBL] [Abstract][Full Text] [Related]
11. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
13. Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?
Hyun SJ; Kim EK; Moon HJ; Yoon JH; Kim MJ
Eur Radiol; 2016 Nov; 26(11):3865-3873. PubMed ID: 26843011
[TBL] [Abstract][Full Text] [Related]
14. The lymph node ratio as prognostic factor in node-positive breast cancer.
Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
[TBL] [Abstract][Full Text] [Related]
17. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of lymph node ratio (LNR) in patients who underwent radical gastrectomy].
Guevara Jabiles A; Ruiz Figueroa E; Berrospi Espinoza F; Chávez Passiuri I; Young Tabusso F; Luque Vásquez C; Poquioma Rojas E; Mantilla R; Payet Meza E
Rev Gastroenterol Peru; 2018; 38(3):253-260. PubMed ID: 30540729
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of node status in different breast cancer subtypes.
Yang ZJ; Yu Y; Hou XW; Chi JR; Ge J; Wang X; Cao XC
Oncotarget; 2017 Jan; 8(3):4563-4571. PubMed ID: 27999188
[TBL] [Abstract][Full Text] [Related]
20. Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
Tsai J; Bertoni D; Hernandez-Boussard T; Telli ML; Wapnir IL
Ann Surg Oncol; 2016 Oct; 23(10):3310-6. PubMed ID: 27401442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
